102 gazette notifications — Page 1 of 3
The National Pharmaceutical Pricing Authority fixes the retail prices for 30 specific drug formulations, exclusive of Goods and Services Tax, under the provisions of the Drugs (Prices Control) Order, …
The National Pharmaceutical Pricing Authority fixes/revises the ceiling price for Benzathine benzylpenicillin, a scheduled formulation, including a WPI impact of 0.64956% for the year 2026.
This corrigendum issued by the National Pharmaceutical Pricing Authority corrects the manufacturer and product/brand names in Table-B, Sl. No. 4, of its previous notification S.O. 1584(E), dated 25.03…
Shri Sd. Aminur Rahman is designated as an "Estate Officer" for Bengal Chemicals & Pharmaceuticals Ltd. (BCPL) under Section 3(a) of the Public Premises (Eviction of Unauthorized Occupant) Act, 1971.
The National Pharmaceutical Pricing Authority fixes the retail prices for 42 specified pharmaceutical formulations, exclusive of Goods and Services Tax, under the powers conferred by the Drugs (Prices…
The National Pharmaceutical Pricing Authority issues an Addendum to its Order No. 1583(E) dated 25.03.2026, concerning ceiling price fixation of scheduled formulation packs of I.V. fluids.
The Central Government appoints Justice Shri G.S. Ahluwalia as Commissioner for the welfare of the victims of the Bhopal gas leak disaster under the Bhopal Gas Leak Disaster (Processing of Claims) Act…
The Central Government amends the n-Butyl Acrylate (Quality Control) Order, 2021, to temporarily suspend the applicability of Indian Standards for n-Butyl Acrylate from April 10, 2026, to July 10, 202…
The Central Government amends the Morpholine (Quality Control) Order, 2020, to temporarily suspend the applicability of Indian Standard conformity for Morpholine from April 1, 2026, to July 1, 2026.
This order amends the Linear Alkyl Benzene (Quality Control) Order, 2022, to temporarily suspend the applicability of Indian Standards for Linear Alkyl Benzene.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specific scheduled formulations, including Piperacillin (A) + Tazobactam (B) Injection, based on the Wholesale Price Index …
This order fixes the ceiling prices for 138 scheduled formulations based on an annual Wholesale Price Index increase, effective from April 1, 2026.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specific scheduled formulations based on the Wholesale Price Index (WPI) of 2025, effective from April 1, 2026.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specified scheduled formulations, including Meropenem, based on the Wholesale Price Index (WPI) of 2025 with a 0.64956% inc…
The National Pharmaceutical Pricing Authority fixes the retail prices for various drug formulations as specified in the accompanying table, exclusive of Goods and Services Tax.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specified scheduled formulations based on the Wholesale Price Index (WPI) of 2025, effective from April 1, 2026.
The National Pharmaceutical Pricing Authority revises the ceiling prices for specific scheduled formulations based on the Wholesale Price Index (WPI) of 2025 with a 0.64956% increase, effective from A…
This Order grants M/s Intas Pharmaceuticals Limited an exemption from the provisions of para 32(ii) of the Drugs (Prices Control) Order, 2013 for their Clozapine Extended Release Capsules 12.5 mg / 25…
This Order revises the ceiling prices of Coronary Stents, effective from April 1, 2026, by the National Pharmaceutical Pricing Authority.
The National Pharmaceutical Pricing Authority fixes ceiling prices for 767 Scheduled formulations, effective from April 1, 2026, incorporating an annual Wholesale Price Index (WPI) increase of 0.64956…
This Corrigendum amends the manufacturer and marketing company names for specific entries in the National Pharmaceutical Pricing Authority's retail price fixation notification S.O. 575(E), dated 09.02…
The National Pharmaceutical Pricing Authority fixes revised ceiling prices for specific scheduled formulations, exclusive of Goods and Services Tax, effective from April 1, 2026, incorporating an annu…
The National Pharmaceutical Pricing Authority exempts M/s Wockhardt Limited from the provisions of the Drugs (Prices Control) Order, 2013 under para 32(i) for its formulation "Nafithromycin Tablets – …
This corrigendum amends the manufacturer and marketing company name for Sl. No. 7 in the National Pharmaceutical Pricing Authority's notification S.O. 5635(E), dated 02.11.2018, regarding retail price…
The National Pharmaceutical Pricing Authority fixes the retail price of specified formulations in exercise of powers conferred by the Drugs (Prices Control) Order, 2013.
This notification introduces the Council (National Institute of Pharmaceutical Education and Research) Amendment Rules, 2026, to amend the Council (National Institute of Pharmaceutical Education and R…
The notification mandates the use of Aadhaar for beneficiaries to avail ex-gratia compensation under the Bhopal Gas Leak Disaster (Registration and Processing of Claims) Scheme, 1985, as per Section 7…
The Government of India mandates the use of Aadhaar for establishing identity to receive ex-gratia compensation under the Bhopal Gas Leak Disaster (Registration and Processing of Claims) Scheme, 1985,…
The National Pharmaceutical Pricing Authority fixes the retail prices, exclusive of Goods and Services Tax, for 36 specified drug formulations with their respective strengths, units, and manufacturer/…
This Order further amends the Textiles — High Density Polyethylene (HDPE) / Polypropylene (PP) Woven Sacks for Packaging of 50 kg Cement (Quality Control) Order, 2023, the Textiles — Polypropylene (PP…
This order fixes the retail prices, exclusive of Goods and Services Tax, for 37 specified drug formulations as per the Drugs (Prices Control) Order, 2013.
The Central Government, through the Ministry of Chemicals and Fertilizers, rescinds six specific Quality Control Orders related to various chemical products, effective immediately.
The National Pharmaceutical Pricing Authority fixes the retail prices for eleven specific drug formulations and brands under the Drugs (Prices Control) Order, 2013.
This notification makes further amendments to S.O. 1490(E), dated 13th September, 2006, under the Chemical Weapons Convention Act, 2000, by substituting 'Ms. Roli Singh Chairperson' for serial number …
The Central Government rescinds six specific Quality Control Orders related to various chemicals, exercising powers under section 16 of the Bureau of Indian Standards Act, 2016.
The National Pharmaceutical Pricing Authority extends the ceiling prices for Orthopaedic Knee Implants for Knee Replacement System.
The Central Government rescinds fourteen previous notifications issued by the Ministry of Chemicals and Fertilizers, relating to various chemical and petrochemical products, under the powers conferred…
This addendum modifies previous orders issued by the National Pharmaceutical Pricing Authority by adding specific manufacturers and their I.V. fluid products to Table 'B' and detailing applicable form…
This addendum modifies previous orders of the National Pharmaceutical Pricing Authority regarding the ceiling price fixation of scheduled formulation packs of Ringer Lactate (non-Glass with special fe…
The National Pharmaceutical Pricing Authority (NPPA) fixes the retail prices, exclusive of Goods and Services Tax, for specific drug formulations as per the table provided in this order.
The National Pharmaceutical Pricing Authority fixes the ceiling prices for specific scheduled formulations, exclusive of Goods and Services Tax, as detailed in the provided table.
This Addendum modifies previous orders by the National Pharmaceutical Pricing Authority regarding ceiling price fixation for scheduled formulation packs of I.V. fluids, adding specific manufacturers a…
The Central Government rescinds three separate Quality Control Orders related to Acrylonitrile, Maleic Anhydride, and Styrene (Vinyl Benzene) with immediate effect.
The Central Government rescinds six specific Quality Control Orders, 2022, pertaining to various fatty acids, with immediate effect, in the public interest.
The Central Government amends the Polypropylene (PP) Materials for Moulding and Extrusion (Quality Control) Order, 2024, by modifying its enforcement date.
The Central Government amends the Scheme for Promotion of Research and Innovation in Pharma MedTech Sector, originally notified on August 16, 2023, by substituting paragraphs 3.2 to 6 and introducing …
This Order further amends the Ethylene Vinyl Acetate Copolymers (Quality Control) Order, 2022, to change its date of coming into force.
The Central Government amends the Ethylene Dichloride (Quality Control) Order, 2021, through the Ethylene Dichloride (Quality Control) Amendment Order, 2025.
The Central Government issues the Polycarbonate (Quality Control) Amendment Order, 2025, to further amend the Polycarbonate (Quality Control) Order, 2021.
This Order further amends the Vinyl Chloride Monomer (Quality Control) Order, 2021, by changing its enforcement date.